These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1838257)

  • 1. An activating amino acid substitution in the c-abl oncogene protein fails to produce a local conformational change.
    Brandt-Rauf PW; Bomzer G; Belford D; Pincus MR
    J Protein Chem; 1991 Aug; 10(4):437-41. PubMed ID: 1838257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins.
    McWhirter JR; Galasso DL; Wang JY
    Mol Cell Biol; 1993 Dec; 13(12):7587-95. PubMed ID: 8246975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
    Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON
    Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.
    Brandt-Rauf PW; Pincus MR; Chen JM
    J Protein Chem; 1989 Dec; 8(6):749-56. PubMed ID: 2576207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.
    Chissoe SL; Bodenteich A; Wang YF; Wang YP; Burian D; Clifton SW; Crabtree J; Freeman A; Iyer K; Jian L
    Genomics; 1995 May; 27(1):67-82. PubMed ID: 7665185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bcr-abl gene in chronic myelogenous leukaemia.
    Sawyers CL
    Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of the cell cycle, differentiation and irradiation on the nuclear location of the abl, bcr and c-myc genes in human leukemic cells.
    Bártová E; Kozubek S; Kozubek M; Jirsová P; Lukásová E; Skalníková M; Buchnícková K
    Leuk Res; 2000 Mar; 24(3):233-41. PubMed ID: 10739005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cells.
    Gishizky ML; McLaughlin J; Pendergast AM; Witte ON
    Oncogene; 1991 Aug; 6(8):1299-306. PubMed ID: 1886706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcr-Abl variants: biological and clinical aspects.
    Advani AS; Pendergast AM
    Leuk Res; 2002 Aug; 26(8):713-20. PubMed ID: 12191565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BCR gene and philadelphia chromosome-positive leukemogenesis.
    Laurent E; Talpaz M; Kantarjian H; Kurzrock R
    Cancer Res; 2001 Mar; 61(6):2343-55. PubMed ID: 11289094
    [No Abstract]   [Full Text] [Related]  

  • 12. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia.
    Jeffs AR; Benjes SM; Smith TL; Sowerby SJ; Morris CM
    Hum Mol Genet; 1998 May; 7(5):767-76. PubMed ID: 9536079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
    Jackson PK; Paskind M; Baltimore D
    Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between the persistence of the BCR/ABL gene and relapse in adult patients with acute lymphoblastic leukemia].
    Anguita E; Villegas A; González FA; del Potro E; Martínez R; Alvarez A; Díaz-Mediavilla J; Ferro MT; Espinós D
    Med Clin (Barc); 1999 Apr; 112(13):481-4. PubMed ID: 10353112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
    Campbell ML; Li W; Arlinghaus RB
    Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.
    Gorre ME; Mohammed M; Ellwood K; Hsu N; Paquette R; Rao PN; Sawyers CL
    Science; 2001 Aug; 293(5531):876-80. PubMed ID: 11423618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localisation and distance between ABL and BCR genes in interphase nuclei of bone marrow cells of control donors and patients with chronic myeloid leukaemia.
    Lukásová E; Kozubek S; Kozubek M; Kjeronská J; Rýznar L; Horáková J; Krahulcová E; Horneck G
    Hum Genet; 1997 Oct; 100(5-6):525-35. PubMed ID: 9341866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia.
    Melo JV; Hochhaus A; Yan XH; Goldman JM
    Br J Haematol; 1996 Mar; 92(3):684-6. PubMed ID: 8616036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho.
    Cicchetti P; Mayer BJ; Thiel G; Baltimore D
    Science; 1992 Aug; 257(5071):803-6. PubMed ID: 1379745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.